Introduction
According to a survey conducted in part by the US Department of Health and Human Services, more than 13 million units of red blood cells (RBCs) were transfused in the United States in 2011. 1 The mean time of storage duration for a unit of RBCs at transfusion was 17.9 days. 1 The maximum allowable storage duration for RBC is defined by the US Food and Drug Administration (FDA) and depends on the storage media. In the United States, AS-1, AS-3, and AS-5 are frequently used as additive solutions and can be stored for up to 42 days at a temperature of 33.8 to 42.8°F (1-6°C) . During the storage of RBCs, well-characterized biochemical, metabolic, structural, inflammatory, and physiological changes occur that are collectively known as the "storage lesion." Although the storage lesion has been well documented and demonstrated in vitro, the clinical relevance of these changes on patient outcomes remains unclear. Ongoing interest exists in the relationship between the duration of RBC storage and clinical outcomes among recipients of transfusions, beginning with the publication of a small, randomized, single-center trial in 1989 that compared the effects of fresh whole blood (< 12 hours old) with stored blood (2-5 days old) in patients who underwent cardiac surgery. 2 Interest in the subject was further galvanized by the publication of a retrospective study by Koch et al 3 who reported that patients who underwent cardiac surgery and received "older" blood (> 14 days old) had worse outcomes than those who received fresher blood (≤ 14 days old). This heightened awareness of the controversy resulted in an increase of observational studies, small studies, randomized controlled trials (RCTs), and phase 3 RCTs to address this issue.
One systematic review provided a detailed summary of relevant publications in adult patients during the last 3 decades . 4 The authors of the review identified 55 studies for detailed qualitative synthesis, most of which were retrospectively performed at a single institution; 8 (14.5%) were small randomized studies, 3 of which were conducted using healthy volunteers. Twenty-six of the studies (47%) suggested that stored RBCs were adversely affected in at least 1 clinical end point, whereas the remaining 29 studies (53%) revealed no difference in effect. The authors concluded that the evidence did not definitively indicate that fresher RBCs were clinically superior to older RBCs. 4 It is worth noting that they did not perform a quantitative meta-analysis due to the considerable heterogeneity among studies and a concern of numerous biased studies they identified in their systematic review. 4 Two other meta-analyses of studies from mostly observational data have resulted in conflicting results. 5, 6 Wang et al 5 performed a meta-analysis on 21 studies published between 2001 and 2011, including 6 studies of cardiac surgery and 6 studies reviewing trauma, that totaled 409,966 patients. They showed that RBC storage was associated with an increased risk of mortality (pooled odds ratio [OR], 1.16; 95% confidence interval [CI]: 1.07-1.24; P = .0001), pneumonia (pooled OR, 1.17; 95% CI: 1.08-1.27; P = .0001), and multiple organ dysfunction syndrome (pooled OR, 2.26; 95% CI: 1.56-3.25; P < .0001). 5 A meta-analysis by Vamvakas et al 6 of studies that included adjusted results for mortality found that the storage duration was not associated with an increased risk of mortality.
There are several possible explanations for the conflicting conclusions from these mostly observational studies. A retrospective study design does not control for known or unrecognized factors that may be clinically important, including baseline patient characteristics, underlying disease, volume transfused, transfusion of other blood components, and follow-up period. Sicker patients receive more blood transfusions than their counterparts, and, thus, have a greater likelihood of receiving at least 1 older unit. An observational study cannot determine whether worse outcomes are due to the need for transfusion or the transfusion itself (confounded by indication). Varied rates of mortality (eg, 7 vs 28 days) and morbidity end points (outcomes) were reported among studies, making comparisons difficult. In addition, various definitions of length of RBC storage were used to define "fresher" versus "older." This issue is particularly problematic when multiple units of various durations of storage are transfused. For example, some used less than 7 days, less than 10 days, or less than 14 days as "fresher," and more than 14 days, more than 21 days, or longer as "older" RBCs. Other studies used the mean age, oldest unit, or oldest of multiple units.
It is worth emphasizing that no clinical evidence supports these "fresh" and "old" definitions. Investigators have inferred that the kinetics of in vitro changes during storage correlate with the in vivo effectiveness of RBCs when defining the age of RBC storage. This approach does not account for the fact that the kinetics of the in vitro changes are variable depending on the parameter, and none has been shown to be clinically relevant. Variable preparations of RBCs, including differing storage media or modifications (eg, leukoreduction), have been used in studies over the years. Leukocytes in the blood products have been reported to affect clinical outcomes via immunomodulation. 7 Rather than replicate a recent systematic review on the subject, 4 in this article we will summarize and contrast key results from previous studies, describe the results of recent publications, and discuss the available data from recently completed RCTs.
In Vitro Changes
In the United States, the FDA has indicated that the maximum "shelf-life" for a unit of RBCs is 42 days when stored in additive solution (eg, AS-1, AS-3, AS-5). The limit on RBC storage duration is primarily based on degree of hemolysis (< 1%) at the end of storage and the percent (minimum, 75%) of the RBCs remaining in the circulation 24 hours following transfusion. 8, 9 The many changes encompassed by the storage lesion occur in a time-dependent manner with kinetics that vary depending on the parameter. 8, 9 There is a progressive decrease in intracellular 2,3-diphosphoglycerate (DPG) and adenosine triphosphate with a concomitant accumulation of extracellular free hemoglobin and free iron. A decrease in 2,3-DPG reduces oxygen delivery to tissue, although this change is reversible after transfusion. Irreversible changes to the RBC membrane, including the release of microvesicles, reduce deformability and may increase the likelihood of occluding microvasculature. Extracellular hemoglobin that is free or contained in microvesicles may scavenge nitric oxide, and iron may increase circulating, nontransferrin-bound iron and, thus, could promote inflammation. [8] [9] [10] There is a progressive accumulation of lactic acid and potassium and a steady decrease in pH during storage. In addition, the accumulation of other biological by-products, including cytokines, lipids, histamines, and enzymes, may induce febrile transfusion reactions, increase oxidative membrane damage, and activate or suppress the immune system. 10 Although the in vitro changes are clear and demonstrable (eg, loss of 2,3-DPG by day 14 of storage), no data exist on the in vivo clinical significance of these changes nor a cutoff point of storage duration to define "older" RBCs. Therefore, defining "older" RBCs (or the age of multiple transfused units) for clinical study is arbitrary, and a fact that, in part, may explain the varied storage duration cutoffs used in many published studies.
Cardiac Surgery
Clinical studies of the duration of RBC storage in patients who underwent cardiac surgery are shown in Table 1 . 2, 3, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] The most well-known of these studies is that of Koch et al, 3 which is a single center, retrospective study of 6,002 patients who underwent cardiac surgery and received transfusions with RBCs between 1998 and 2006. A total of 2,872 patients received 8,802 units of blood stored for 14 days or less ("fresher"), and 3,130 patients received 10,782 units of blood stored for more than 14 days ("older"). Recipients of older RBCs (median, 20 days) had higher rates of hospital mortality compared with those who received fresher RBCs (median, 11 days; 2.8% vs 1.7%; P = .004). Compared with those who received fresher RBCs, recipients of older RBCs also had a higher rate of 1-year mortality (7.4% vs 11.0%; P < .001), were more likely to require prolonged support on mechanical ventilation (MV) beyond 72 hours (9.7% vs 5.6%; P < .001), and more likely to have renal failure (2.7% vs 1.6%; P = .003), sepsis or septicemia (4.0% vs 2.8%; P = .01), or multisystem organ failure (0.7% vs 0.2%; P = .007). 3 Of note, the conclusions of this study have been debated and challenged primarily because of the observational nature of the study and the presentation of unadjusted analyses. 23 Several studies of patients who underwent cardiac surgery were unable to find similar associations. 15 analyzed the data of 821 patients who underwent cardiac surgery and found that the transfusion of RBCs stored for more than 14 days was not associated with adverse outcomes. The incidences of the primary outcome (composite end point of death, myocardial infarction, and stroke) were 8.6% and 4.5% in the "any older" group (RBC age, 21 ± 5 days) and the "fresher" group (RBC age, 13 ± 2 days), respectively (adjusted OR, 1.68; 95% CI: 0.65-4.34). 15 Rates of prolonged ICU stays were 12.3% and 6.3% in the "any older" and "fresher" groups, respectively (adjusted OR, 1.58; 95% CI: 0.69-3.66). 15 In addition to the reports on mortality outcomes, several investigators assessed the possible association between length of RBC storage and other clinical parameters, such as occurrence of infections, ICU and hospital LOS, as well as organ failure in transfused patients. Vamvakas et al 16 reported on an independent relationship between the storage duration of RBCs and postoperative pneumonia or wound infections among 256 patients who received transfusions and underwent CABG surgery, discovering that the risk of pneumonia increases by 1% for every additional day of mean storage length of RBCs (P < .005). Leal-Noval et al 17 found that the oldest unit transfused (> 28 days), but not the mean age of all transfused units, correlated with the development of postoperative pneumonia (OR, 1.06; 95% CI: 1.01-1.11). However, they did not find a correlation between the mean duration of storage with prolonged ICU LOS (> 4 days), prolonged length of MV support (> 24 hours), or perioperative infarction, mediastinitis, or sepsis. 17 A subsequent study by Vamvakas et al 18 reported no association between duration of RBC storage and postoperative ICU and hospital LOS. Andreasen et al 19 investigated 1,748 patients receiving CABG and found that, compared with patients not receiving transfusions, the adjusted ORs for severe infection among all transfusion recipients and recipients of fresher (< 14 days; n = 953) or older (≥ 14 days; n = 548) RBCs were 1.6 (95% CI: 0.9-2.8), 1.1 (95% CI: 0.6-2.1), and 2.3 (95% CI: 1.2-4.2), respectively. In a retrospective study of 444 patients undergoing cardiac surgery, Sanders et al 20 found that patients who exclusively received older RBCs (> 14 days) or any older blood (older blood, fresher blood, or a mixture of both) had a longer postoperative LOS and a higher incidence of new renal complications than patients who received transfusions with fresher RBCs.
Two recent retrospective studies reviewed data from pediatric patients who underwent cardiac surgery. 21 
Trauma
Studies on the effects of RBC storage among patients with trauma have generated conflicting results ( Table 2) . [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] Zallen et al 24 performed a retrospective review of a prospectively collected database and found that the mean age of blood or number of units for more than 14 or 21 days was an independent risk for multiorgan failure among the 63 patients studied. Keller et al 25 reported that the number of units older than 14 days was associated with an increased hospital LOS, but not the duration of MV support in 86 patients with trauma. Offner et al 26 found the number of transfused units that had been stored for 14 or 21 days was associated with an increased risk for infection. Weinberg et al 27 reported that transfusion of large (but not small) volumes of older blood was associated with increased rates of mortality among 1,813 patients with severe trauma (mean injury severity score [ISS], 26]. In a report of patients with less severe traumatic injury (mean ISS, 14.4), Weinberg et al 28 found that the transfusion of older blood (> 14 days old) was associated with a slightly increased rate of mortality (OR, 1.12; 95% CI: 1.02-1.23). The same authors later reported that a higher mortality rate occurred in patients receiving transfusions with at least 3 units of older blood (≥ 14 days) compared with those who received at least 3 units of fresher RBCs (adjusted RR, 1.57; 95% CI: 1.14-2.15). 29 In a retrospective analysis of 202 patients with trauma who received at least 5 units of RBCs, Spinella et al 30 In a prospective, observational study, Leal-Noval et al 32 assessed the effects of RBC transfusion on cerebral tissue oxygenation (PtiO 2 ) in 66 patients with traumatic brain injury. The duration of RBC storage was divided into 4 groups: less than 10 days (n = 18), 10 to 14 days (n = 15), 15 to 19 days (n = 17), and more than 19 days (n = 16). They observed a significant increase in PtiO 2 after the transfusion of RBCs stored for less than 19 days, but they saw no significant changes in PtiO 2 after the transfusion of RBCs stored for more than 19 days. Kiraly et al 33 performed a prospective, nonrandomized study in 32 trauma patients in the ICU who were hemodynamically stable and nonseptic. Seventeen of those patients transfused with older blood (≥ 21 days) demonstrated a significant decline in the area under the curve for tissue oxygen saturation (StO 2 ) as measured by near-infrared spectroscopy. 33 Patients transfused with fresher blood (< 21 days old) and a control group not receiving transfusions had no similar rate of decline in the area under the curve for StO 2 . They found a moderate correlation between increasing the duration of RBC storage and decreasing the oxygenation (r = 0.5). 33 Weinberg et al 34 evaluated microvascular perfusion in 93 stable patients with trauma (mean ISS, 26.4) during RBC transfusion and found that the transfusion of relatively older RBCs was associated with a decline in both StO 2 and perfused capillary density.
Other studies have produced mixed results (see Table 2 ). Murrell et al 35 studied 275 patients and found that older blood was associated with longer stays in the ICU (RR, 1.15; 95% CI: 1.11-1.20) but not higher rates of hospital mortality (OR, 1.21; 95% CI: 0.87-1.69). In a cohort of 820 patients with trauma, Hassan et al 36 found that the total number of RBC units but not the number of older (> 14 days old) RBC units transfused was associated with an increased rate of mortality. However, the number of older units was a significant risk factor for severe sepsis or septic shock, particularly when more than 7 units were transfused (OR, 1.9; 95% CI: 1.1-3.4; P = .03). 36 In a retrospective study of 196 patients with trauma who received transfusions, Juffermans et al 37 found a modest correlation between transfused RBCs stored for longer than 14 days and the occurrence of new infections (OR, 1.04; 95% CI: 1.01-1.07).
Critical Care
Regarding the adverse effects of prolonged RBC storage on clinical outcomes, conflicting analyses have also been reported among patients who are critically ill (Table 3) . [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] Purdy et al 38 reported that, of the 31 patients they studied who were admitted to the ICU with severe sepsis, the median age of RBC units 43 Several investigators have assessed the relationship between duration of RBC storage and pulmonary function or the risk of acute lung injury (ALI) in patients in the ICU. In a retrospective analysis of 181 patients in the ICU, Gajic et al 44 found no association between mean age or age of the oldest unit transfused and occurrence of ALI. Kor et al 45 performed a small, double-blind, randomized, single-center trial of 100 patients in the ICU on MV support to compare the effects of fresher RBCs (median age, 4 days) with standard RBCs (median age, 26.5 days). They found no significant difference in the primary outcome of pulmonary function assessed by the partial pressure of arterial oxygen to the fraction of inspired oxygen concentration ratio as well as the immunological and coagulation status between the 2 groups. A similar rate of mortality was seen among the fresher and standard-issue RBC groups, but the study was not powered for this outcome. 45 Janz et al 46 assessed whether the duration of RBC storage was associated with the risk of developing ALI in a cohort of 96 patients in the ICU who were septic and had received transfusions. They found that the median storage duration of transfused RBCs in patients with ALI/acute respiratory distress syndrome (ARDS) was longer (24.5 days; interquartile range, 20-31 days) compared with patients without ALI/ARDS (21 days; interquartile range, 15-27 days; P = .018). The same association was not seen in the 176 trauma patients in the ICU who received transfusions or in 125 patients in the ICU who were not septic, had no trauma, and had received transfusions. 46 In a prospective study of 261 patients in the ICU, Katsios et al 47 reported no association between the storage duration of transfused RBCs and the development of deep venous thrombosis. A previous study of patients with trauma found an association between the maximum age of transfused RBCs (> 21 or 28 days) and the occurrence of deep venous thrombisis, but no multivariate analysis was performed. 30 Several studies have addressed whether older RBCs adversely affect microcirculation or tissue oxygenation (see Table 3 ). [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] Marik et al 48 found an inverse relationship between the duration of RBC storage and the maximal changes in gastric mucosal pH (pHi) in 23 patients in the ICU who were septic (r = -0.71; P < .001). However, later studies did not confirm this finding. In a small, randomized study of 15 septic patients, Fernandes et al 49 compared the transfusion of either 1 RBC unit (mean age, 12.8 ± 8.1 days) or 500 mL of albumin solution and found no correlation between the storage duration of transfused RBCs and pHi. In another double-blind, randomized study of 22 patients in the ICU, Walsh et al 50 compared the effects of transfusing 2 units of leukoreduced RBCs, which were stored for either no more than 5 days (median, 2 days) or for at least 20 days (median, 28 days) and found no difference in pHi or gastric-to-arterial PCO 2 gap. Sakr et al 51 assessed transfusion-induced changes in the sublingual microcirculation of 35 patients in the ICU with sepsis following the administration of either 1 or 2 units of leukoreduced RBCs (mean storage, 24 days; interquartile range, 12-28 days) and found no effect of the duration of RBC storage on the changes of microvascular flow. Creteur et al 52 evaluated 44 patients in the ICU for oxygenation and microvascular reactivity using near-infrared spectroscopy and found no association between the duration of RBC storage and oxygen variables. Kopterides et al 53 reviewed the data from 37 patients in the ICU with sepsis and found no relationship between the duration of RBC storage and change in the lactate:pyruvate ratio (microdialysis).
Cancer and Other Patient Populations
Several studies have addressed the effects of RBC storage among patients with cancer, those undergoing liver transplantation, those receiving transfusions, and mixed patient populations, among others (Table 4) . [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] Several earlier studies reported on the effects of RBC storage duration on postoperative infections in patients undergoing surgery for colorectal cancer. [54] [55] [56] In a retrospective study of 466 consecutive patients who underwent resection for colorectal cancer between the years 1980 and 1992 in Norway, Edna et al 54 analyzed 290 patients who received a transfusion of nonfiltered blood and found that infections were more likely to occur in the patients who received transfusions (31%) than in patients who did not receive transfusions (13%; P < 0.001). However, the median storage time of blood transfused to patients with infectious complications (18 days; range, 2-35 days) was no different from those without infections (20 days; range, 1-37 days; P = .10). 54 Mynster et al 55 retrospectively analyzed transfusion data from a prospectively acquired database of 303 patients who underwent resection of colorectal carcinoma in Denmark; 225 of these patients received transfusions. The overall infection rate was higher in patients who received a transfusion (40%) compared with those who had not received a transfusion (24%; P = .011). A multivariate analysis showed that the transfusion of blood stored for at least 21 days correlated with the rate of postoperative infection (intra-abdominal abscess, anastomotic leakage, wound infection, pneumonia, and septicemia). The OR was 2.35 (95% CI: 1.27-4.37; P = .007). 55 The same investigators published another analysis of 740 patients from the same prospectively acquired database and discovered a higher rate of cancer recurrence in patients who received blood exclusively stored for less than 21 days (hazard ratio [HR]: 1.5; 95% CI: 1.1-2.2) than patients who received blood stored for at least 21 days. 56 One decade later, Cata et al 57 studied 316 patients who underwent surgery for prostate cancer and did not find an association between the duration of RBC storage and the 5-year biomedical (defined by prostate-specific antigen level) recurrence of cancer following radical prostatectomy. At 5 years, the recurrence-free survival rates were 74%, 71%, and 76% for patients who received younger (≤ 13 days), middle (13-18 days), and older (≥ 18 days) aged RBCs, respectively (P = .82; Wald test). 57 A retrospective study by Kekre et al 58 analyzed the data from 1,929 patients with cancer who received a transfusion within 1 year of a diagnosis of cancer and found that the overall survival rates were not associated with the storage duration of transfused RBCs. Median survival rates were 1.2, 1.7, and 1.1 years for the patients who received exclusively fresher (< 14 days), intermediate (14-28 days) , or older (> 28 days) units of RBCs, respectively (P = .36). 58 The same authors had also studied the data of 555 patients who received transfusions during hematopoietic stem cell transplantation and found that the proportion of older units (≥ 15 days) and the mean age of the transfused RBCs did not correlate with rates of 100-day nonrelapse mortality, LOS, or ICU admission (P > .05). 59 Yuruk et al 60 performed a small randomized trial of 20 hematology patients and found that changes in microcirculatory density and hemorheologic properties were similar between the fresher RBC group (median, 7 days [interquartile range, 5-7 days]) and older RBC groups (median, 23 days [interquartile range, 22-28 days]).
Two studies of patients receiving liver transplantation also generated conflicting conclusions. Dunn et al 61 retrospectively analyzed 509 patients receiving liver transplantations and reported that no independent association existed between the duration of RBC storage and postoperative infections, organ rejection, or death. Patients who received more blood had an increased risk for death. 61 However, Cywinski et al 62 analyzed 637 patients receiving liver transplantations and found that the risk for graft failure and mortality was significantly higher in recipients of older RBC units (> 15 days old) compared with recipients of fresher RBC units (HR, 1.65; 95% CI: 1.18-2.31). The authors concluded that patients who intraoperatively received older RBCs had an increased risk for adverse outcomes. 62 Several large studies have reported outcomes on mixed patient populations. Edgren et al 63 reported on a large data set of 404,959 transfusion episodes in more than 300,000 patients (mostly trauma and surgical) derived from the Swedish and Denmark Scandinavian Donations and Transfusions' database from 1995 to 2002. 63 During a 2-year follow-up, an increased mortality rate of 5% was seen among patients transfused with RBCs that were stored for 30 to 42 days compared with patients who received RBCs that were stored for 10 to 19 days (HR, 1.05; 95% CI: 0.97-1.12). 63 No dose effect, no pattern for cause of mortality, and no change in mortality over time were seen, leading the authors to state that the small excess risk was most consistent with weak confounding. 63 Two studies examined patients with cardiovascular disease. 64 In a retrospective analysis of nearly 7,000 patients who received transfusions for general (noncardiac) surgery, Saager et al 66 found no association between the median duration of storage and risk of postoperative mortality (HR, 0.99; 95% CI: 0.94-1.04; P = .64). In a retrospective analysis of 335 patients who underwent knee arthroplasty, Basora et al 67 found no independent association between the age of transfused RBCs and postoperative wound infection. However, Lee et al 68 analyzed 261 patients who underwent surgery for breast reconstruction and found that postoperative complications (vascular thrombosis, hematoma, and flap congestion) were higher in patients who received older blood (44.1%; RBC age > 14 days) compared with those who received fresher blood (20.0%, RBC age ≤ 14 days) or no transfusion (12.8%; P < .05).
In a retrospective analysis of 8,971 patients who received transfusions, including both inpatients and outpatients, Middelburg et al 69 found an almost 2-fold increase in mortality rate for recipients of fresher RBCs compared with older RBCs (HR, 0.56; 95% CI: 0.32-0.97 for RBC stored > 24 days compared with < 10 days). A similar report of the adverse events of fresher blood was previously published by Mynster et al. 56 They found a higher rate of cancer recurrence in patients who received RBCs stored for less than 21 days (HR, 1.5; 95% CI: 1.04-2.18). 56 These 2 studies suggest that fresher RBCs may have potentially detrimental effects in some patient populations.
The results from observational studies and small RCTs, both of which represent the body of literature on the subject, are mixed, and these studies have substantial methodological limitations. The strong correlation between the decision to transfuse and the severity of the underlying illness limits the interpretations from observational studies.
Randomized Controlled Trials
More than 25 years ago, the first prospective RCT of RBC storage was conducted and involved 237 patients who were randomized to receive 2 units of either fresh whole blood (< 12 hours) or stored blood (2-5 days) at the end of the extracorporeal circulation in a primary coronary bypass operation. 2 No differences were seen in postoperative bleeding, coagulation tests, or transfusion requirements between the 2 groups. 2 Since then, several small, prospective RCTs have been conducted; however, these trials are limited by their low numbers of participants (Table 5) . 2, 45, 49, 50, 60, [70] [71] [72] Given the inconclusive findings from retrospective studies and the small number of study participants from the historical RCTs, 2 large, properly powered, multicenter RCTs have been reported. One study evaluated 377 infants born premature with very-low birth weight (< 1250 g) in a neonatal ICU who required at least 1 RBC transfusion. 70 70 The RR was 1.00 (95% CI: 0.82-1.21) for the primary outcome of the study, a composite measure of necrotizing enterocolitis, retinopathy of prematurity, intraventricular hemorrhage, bronchopulmonary dysplasia, and death. The rates of clinically suspected infection were 77.7% and 77.2% for the fresher RBC and standard-care RBC groups, respectively (RR, 1.01; 95% CI: 0.90-1.12). 70 Rates of positive cultures were 67.5% and 64.0% for the fresher RBC and standard RBC groups, respectively (RR: 1.06; 95%: 0.91-1.22). 70 Hence, this RCT demonstrated that the use of fresher RBCs compared with standard care did not decrease or increase the rate of complications or death in this population of premature, very-low birth weight neonates. 70 A study conducted by Steiner et al 72 enrolled 1,613 patients undergoing cardiac surgery, 1,418 of whom were randomized to receive leukoreduced RBCs stored for either no more than 10 days (fresher) or 21 days or longer (older). A total of 1,096 patients receiving transfusions within 96 hours following surgery were evaluable and analyzed for changes in multiorgan dysfunction score from prior to surgery to the highest composite change in multiorgan dysfunction score through day 7 (or death or discharge, if earlier), adverse events, and 28-day mortality. A total of 538 patients received a median of 4 units of fresh RBCs (median storage age, 7 days), and 560 patients received a median of 3 units of older RBCs (median storage age, 28 days). No difference was seen in the median composite change in multiorgan dysfunction score at day 7 (8.48 in the fresh RBC group vs 8.66 in the older RBC group; P = .42). 72 A total of 53% and 51% of the patients in the fresh and old groups, respectively, developed a serious adverse event.
All-cause mortality rates at day 28 were 4% in patients who received fresh RBCs and 5% in patients who received old RBCs. 72 The study concluded that RBC storage duration was not significantly associated with 7-day changes in multiorgan dysfunction score, serious adverse events, or 28-day mortality rates among patients undergoing cardiac surgery. 72 Another recent trial, the Age of Blood Evaluation (ABLE) study, is a multicenter RCT of critically ill Canadian patients and was funded by the Canadian Institute of Health Research (MCT-90648). This study involved 2,420 patients in the ICU randomized to receive RBCs less than 7 days old or standard-issue RBCs. The primary end point was 90-day mortality. The preliminary results of this study were presented at a recent critical care meeting in Toronto, Canada. 73 The average age of the RBCs in the fresh group was 6.1 ± 4.9 days compared with 22.0 ± 8.5 days in the standard-issue group. The 90-day mortality rate in the intent-to-treat patients was not different between the groups (absolute risk reduction, 1.57% [95% CI: -2.25-5.40]). Thus, the preliminary results from this study are consistent with the other large randomized trials showing no difference in clinical outcomes associated with longer compared with shorter stored RBCs.
Conclusions
Observational studies of the clinical effects of the storage duration of red blood cells are conflicting and have methodological limitations; in addition, they are confounded by indication. These limitations are best addressed by randomized controlled trials. A number of published and reported randomized controlled trials -1 in adults, 1 in pediatrics, and 1 recently reported -provide strong evidence that the storage duration of red blood cells does not have measur able adverse effects on the clinical outcomes in select transfused patient populations. Additional randomized controlled trials are underway in the critically ill and medical/surgical patient populations. Together, these random ized controlled trials will define whether the storage duration of red blood cells has clinical relevance.
